As a member of the firm’s M&A group, Ro guides his clients through high-stakes public and private mergers and acquisitions, venture capital financings, and securities offerings representing an aggregate value of more than $224 billion. He focuses on cutting-edge technology and biotechnology transactions, and is one of the go-to M&A advisers for complex cross-border transactions in these fields. Ro also regularly advises boards of directors and special committees on activist defense, proxy contests, and corporate governance matters.

Download full bio 


  • Digital Shadows Agrees to Sell to ReliaQuest 

  • Biotech Company ViaCyte to Be Acquired by Vertex Pharmaceuticals 

  • Bristol Myers Squibb to Acquire Turning Point Therapeutics for $4.1 Billion 

  • Meredith Agrees to Sell National Media Group to IAC’s Dotdash 

  • Japan’s Paidy Agrees to Sell to PayPal for $2.7 Billion 

  • View all


  • University of Pennsylvania Law School

  • The Wharton School of the University of Pennsylvania
    Wharton Business and Law Certificate

  • Seoul National University School of Law

Admissions & Credentials


New York